Generex Biotechnology Corp. (GNBT)
Delisted
29 Dec 2022
OTCQB OTCQB Primary $
0. 00
-0
-50%
$
- Market Cap
- P/E Ratio
- Div Yield
15,763 Volume
- Eps
$ 0
Previous Close Investors:
Day Range
0 0
Year Range
0 0.08
Want to track GNBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
GNBT Chart
Generex Biotechnology Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MLG Michael L. Gravelle Fidelity National Financial Inc. | 14,967.42 | $38,002.29 | $12,512.64 | -$25,489.65 | -67.07% |
Generex Biotechnology Corp. (GNBT) FAQ
What does "Delisted" mean?
Generex Biotechnology Corp. has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
No dividend payments were recorded prior to delisting.
How long did the company pay dividends?
The company did not have a dividend payment history.
Were there any stock splits?
The last recorded stock split occurred on Feb 25, 2020 with a ratio of 7:5.
What was the last known trading price?
The stock last traded at $0.00 on Dec 29, 2022 before being delisted.
